Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CRON stock hub

Cronos Group Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CRONis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

953.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CRON

In the news

Latest news · CRON

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E47.6

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-0.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-5.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CRON market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001603447
Company name	Cronos Group Inc.
Country	Canada
Country code	US
Cusip	22717L101
Employees	610
Employees Change	151%
Employees Change Percent	32.9
Enterprise value	$171.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA22717L1013
Last refreshed	2026-05-10
Market cap	$953.8M
Market cap category	Small-Cap
Price	$2.54
Price currency	USD
Rev Per Employee	240,306.56x
Sector	Healthcare
Symbol	CRON
Website	https://thecronosgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.99%
EV Sales Forward	0.81x
EV/FCF	1,149.74x
EV/Sales	1.17x
FCF yield	0.02%
Forward P/E	47.63x
P/B ratio	0.83x
P/S ratio	6.51x
PS Forward	4.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-11.61%
EBITDA Margin	-2.29%
FCF margin	0.1%
Gross margin	39.84%
Gross Profit	$58.4M
Gross Profit Growth	91.59%
Gross Profit Growth Q	79.22%
Gross Profit Growth3 Y	55.82%
Net Income	$-9.4M
Net Income Growth Years	0%
Pretax Margin	-11.68%
Profit Margin	-6.44%
Profit Per Employee	$-15,487
ROA	-0.9
Roa5y	-3.85
ROCE	-1.48
ROE	-0.26
Roe5y	-4.78
ROIC	-5.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	37.33%
Cagr3y	8.11%
Cagr5y	-19.87%
EPS Growth Years	0
FCF Growth	-97.68%
FCF Growth Q	132.13%
OCF Growth	37.27%
OCF Growth Q	53.3%
Revenue Growth	24.63x
Revenue Growth Q	46.96x
Revenue Growth Quarters	10x
Revenue Growth Years	9x
Revenue Growth3 Y	19.11x
Revenue Growth5 Y	25.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.12
Assets	$1.2B
Cash	$831.8M
Current Assets	$944.1M
Current Liabilities	$48.2M
Debt	$1.5M
Debt Equity	$0
Debt FCF	$10.13
Equity	$1.1B
Liabilities	$54.2M
Long Term Assets	$253.1M
Long Term Liabilities	$6M
Net Cash	$830.3M
Net Cash By Market Cap	$87.05
Net Cash Growth	-3.09%
Net Debt Equity	$-0.73
Net Debt FCF	$-5,572
Tangible Book Value	$1B
Tangible Book Value Per Share	$2.67
WACC	11.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	19.59
Inventory Turnover	2.21
Net Working Capital	$64.4M
Quick ratio	18.45
Working Capital	$895.9M
Working Capital Turnover	$0.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.54%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	37.3%
200-day SMA	2.57
3Y total return	26.37%
50-day SMA	2.59
50-day SMA vs 200-day SMA	50over200
5Y total return	-66.97%
All Time High	25.1
All Time High Change	-89.88%
All Time High Date	2019-02-04
All Time Low	0.17
All Time Low Change	1,439.39%
All Time Low Date	2016-07-12
ATR	0.11
Beta	1.23
Ch YTD	-3.42
High	2.62
High52	3.43
High52 Date	2025-12-15
High52ch	-25.95%
Low	2.52
Low52	1.84
Low52 Date	2025-06-23
Low52ch	38.04%
Ma50ch	-1.78%
Premarket Change Percent	-0.39
Premarket Price	$2.56
Premarket Volume	1,797
Price vs 200-day SMA	-0.97%
RSI	43.52
RSI Monthly	51.39
RSI Weekly	49.03
Sharpe ratio	0.82x
Sortino ratio	1.57
Total Return	0.54%
Tr YTD	-3.42
Tr1m	0.79%
Tr1w	-3.79%
Tr3m	-3.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$0.01
Earnings EPS Estimate Growth	-50
Earnings Revenue Estimate	54,513,600x
Earnings Revenue Estimate Growth	68.97x
Operating Income	$-17M
Operating margin	-11.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	194,910,022%
Float Percent	51.42%
Shares Insiders	6.59%
Shares Institutions	15.03%
Shares Out	379,051,102
Shares Qo Q	-0.64%
Shares Yo Y	-0.54%
Short Float	2.34%
Short Ratio	4.93
Short Shares	1.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-6.9M
Average Volume	2,052,206.25x
Bv Per Share	2.87
CAPEX	$-25.7M
Ch1m	0.79
Ch1w	-3.79
Ch1y	37.3
Ch3m	-3.79
Ch3y	26.37
Ch5y	-66.97
Ch6m	2.42
Change	-1.17%
Change From Open	-1.17
Close	2.57
Days Gap	0
Depreciation Amortization	13,662,000
Dollar Volume	3,087,580.8
Earnings Date	2026-05-11
Earnings Time	bmo
EBIT	$-17M
EBITDA	$-3.4M
EPS	$-0.02
F Score	5
FCF	$149,000
FCF EV Yield	0.09x
FCF Per Share	$0
Financing CF	-19,905,000
Fiscal Year End	December
Goodwill	66,478,000
Income Tax	$-14.2M
Investing CF	-76,559,000
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Last Split Type	Never
Ma150	2.6
Ma150ch	-2.31%
Ma20	2.65
Ma20ch	-4.22%
Net CF	-67,011,000
Next Earnings Date	2026-05-11
Open	2.57
Optionable	Yes
P FCF Ratio	6,401.3
P OCF Ratio	36.87
Position In Range	20
Post Close	2.54
Postmarket Change Percent	2.76
Postmarket Price	$2.61
Ppne	147,287,000
Pre Close	2.57
Price Date	2026-05-08
Ptbv Ratio	0.94
Relative Volume	0.59x
Revenue	146,587,000x
SBC By Revenue	4.81x
Share Based Comp	7,050,000
Tax By Revenue	-9.68x
Tr6m	2.42%
Volume	1,215,583
Z Score	10.8

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CRON pay a dividend?

Capital-return profile for this ticker.

Performance

CRON stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CRON?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.0%

Float: +51.4% of shares outstanding

Insider ownership

+6.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CRON momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.5

Neutral momentum band

Price vs 200-day MA

-1.0%

50/200-day relationship not available

Beta (5Y)

1.23

More volatile than the market

Sharpe ratio

0.82

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CRON

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CRON stock rating?

Cronos Group Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CRON analysis?

The full report lives at /stocks/CRON/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CRON?

The latest report frames CRON around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CRON page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.